Zobrazeno 1 - 10 of 31 pro vyhledávání: '"Mary E. Gordinier"'
1
A multicenter open-label randomized phase II trial of paclitaxel plus EP-100, a novel LHRH receptor-targeted, membrane-disrupting peptide, versus paclitaxel alone for refractory or recurrent ovarian cancer
Autor: Mary E. Gordinier, Alpa Nick, Anca Chelariu-Raicu, Carola Leuschner, John K. Whisnant, Linda M Bavisotto, Renata R. Urban, Robert L. Coleman, Graziela Zibetti Dal Molin
Publikováno v: Gynecologic Oncology. 160:418-426
Objective This randomized open-label phase II study evaluated the safety and clinical activity of EP-100 plus weekly paclitaxel in patients with recurrent ovarian cancer expressing positive LHRH receptor. Methods In a limited “run-in” dose escala
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb50bb89d5a20fa13d9a86bfc753888
https://doi.org/10.1016/j.ygyno.2020.11.013
Zobrazit plný text záznamu
2
Gender and the Balance of Parenting and Professional Life among Gynecology Subspecialists
Autor: Stephen Fiascone, Mary E. Gordinier, Ashley Stuckey, Amy Brown, Katina Robison, Christina Raker, Melissa A. Clark, Emily K. Hill
Publikováno v: Journal of Minimally Invasive Gynecology. 26:1088-1094
STUDY OBJECTIVE To compare the parenting and career patterns of female and male gynecology subspecialists. DESIGN Cross-sectional survey study (Canadian Task Force classification II-3). SETTING Survey administered electronically in February 2015 to p
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3172f13805d60a4dcebac6082842d60
https://doi.org/10.1016/j.jmig.2018.10.020
Zobrazit plný text záznamu
4
Impact of Screening for Sexual Trauma in a Gynecologic Oncology Setting
Autor: Mary E. Gordinier, Lisa B E Shields, Douglas J. Lorenz, Mary Helen Davis, Sibyl Cagata
Publikováno v: Gynecologic and obstetric investigation. 86(5)
Objectives: Sexual trauma poses a significant concern and is associated with heightened stress, negative health repercussions, and adverse economic effects. A history of abuse may increase a woman’s risk of developing cancer, in particular cervical
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9c339ad08401d9e40cdac825d5efa67
https://pubmed.ncbi.nlm.nih.gov/34515127
Zobrazit plný text záznamu
5
Pembrolizumab in Recurrent Squamous Cell Carcinoma of the Vulva: Case Report and Review of the Literature
Autor: Lisa B E Shields, Mary E. Gordinier
Publikováno v: Gynecologic and obstetric investigation. 84(1)
Advanced vulvar cancer is associated with a very poor prognosis. Surgical resection is the mainstay of treatment, with radiation indicated for areas at high risk for recurrence. When surgical and radiation options have been exhausted, the effectivene
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e1ad643b7e6d960ea7181ba0dce9e43
https://pubmed.ncbi.nlm.nih.gov/30016784
Zobrazit plný text záznamu
7
Geographic Disparities in Cancer Survival and Access to Care
Autor: Mary E. Gordinier, Carol Hanchette
Publikováno v: International Journal of Applied Geospatial Research. 1:67-79
From 1995-2005, ovarian cancer accounted for 2.7% of new cancer cases diagnosed among women in Kentucky and was responsible for 4.7% of female cancer deaths in the state. The five-year survival rate for ovarian cancer is 45% for all stages combined.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::602ba86eff0e815882d51358d71a6cdd
https://doi.org/10.4018/jagr.2010071605
Zobrazit plný text záznamu
8
Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity
Autor: Mary E. Gordinier, C. R. Toler, C. W. Helm, Daniel S. Metzinger, Lynn P. Parker, Robert P. Edwards, R. S. Martin
Publikováno v: International Journal of Gynecologic Cancer. 17:204-209
Our experience with hyperthermic intraperitoneal chemotherapy (IPHC) in conjunction with surgical resection for endometrial cancer recurrent within the abdominal cavity was reviewed. Eligible patients underwent exploratory laparotomy with the aim of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb00d0ec620dcb5b666a8d92798f16a8
https://doi.org/10.1111/j.1525-1438.2006.00751.x
Zobrazit plný text záznamu
9
Two for good measure: Six versus eight cycles of carboplatin and paclitaxel as adjuvant treatment for epithelial ovarian cancer
Autor: Jane Miller, Leslie Pires, Trevor Tejada-Berges, Mary E. Gordinier, Don S. Dizon, Robert D. Legare, Cornelius O. Granai, Paul DiSilvestro, Joanna Schwartz, Sherry Weitzen, Adam Rojan, Richard G. Moore
Publikováno v: Gynecologic Oncology. 100:417-421
Although the standard of care for advanced epithelial ovarian cancer (EOC) is six cycles (6C) of platinum-taxane (PT), there have been no studies on the optimal duration of treatment in the era of adjuvant taxanes. At our center, some women receive e
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7de54bf74199f3cf75b2e2a3cbad68d2
https://doi.org/10.1016/j.ygyno.2005.10.031
Zobrazit plný text záznamu
10
Dyspnea during Thalidomide Treatment for Advanced Ovarian Cancer
Autor: Mary E. Gordinier, Don S. Dizon
Publikováno v: Annals of Pharmacotherapy. 39:962-965
OBJECTIVE:To detail the dyspnea encountered in women receiving thalidomide as therapy for advanced ovarian cancer.CASE SUMMARIES:Eight of 18 (44%) patients with recurrent ovarian cancer developed dyspnea while receiving thalidomide 200 mg daily as pa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc786c85031d2245c55048743d8cda1
https://doi.org/10.1345/aph.1e608
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje